View
How Real-World Clinico-Genomic Data is Delivering New Cancer Insights
Real-world clinico-genomic data is recognized across the healthcare community as a catalyst to spur potentially life-changing advancements in care and has become instrumental in our joint work to improve outcomes for patients with cancer. By analyzing this data, we can zoom in on niche patient populations to answer questions such as how patients with specific genomic signatures respond to a given treatment.
From the Foundation Forward Blog
-
December 01, 2021
Finding Answers, Empowering Action
-
September 17, 2021
How Real-World Clinico-Genomic Data is Delivering New Cancer Insights | Foundation Medicine
-
August 26, 2021
What a Difference a Year Makes: The Evolving Landscape of Pan-Tumor Liquid Biopsy Testing | Foundation Medicine
-
August 03, 2021
Making Comprehensive Genomic Profiling Indispensable at a Global Level: Progress, Perspectives and What’s Next | Foundation Medicine
-
July 15, 2021
Companion Diagnostics Explained: Their Critical Role in Cancer Care and Our Latest Approvals | Foundation Medicine